ALNYLAM PHARMACEUTICALS, INC. 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Jan 5, 2015
Insider Transaction Report
Form 4
Reid Laurence
SVP, Chief Business Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2014-12-31−17,000→ 133,609 totalExercise: $15.99Exp: 2020-06-11→ Common Stock (17,000 underlying) - Exercise/Conversion
Common Stock
2014-12-31$15.99/sh+17,000$271,830→ 20,905 total - Tax Payment
Common Stock
2014-12-31$97.00/sh−2,802$271,794→ 18,103 total
Holdings
- 1,766(indirect: By Managed Account)
Common Stock
Footnotes (2)
- [F1]The reporting person owns 1,766 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- [F2]The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.